Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Bill Banning “Reverse Settlements” Would Give FTC Exemption Power

Executive Summary

A bill introduced by Rep. Bobby Rush, D-Ill., banning "reverse" settlements between brand and generic companies would give the Federal Trade Commission the power to allow any such agreement it deems furthers market competition

You may also be interested in...



Brand/Generic Settlements Return To Capitol Hill

Apotex could make its case for scrapping first-to-file exclusivity during a hearing in Rep. Rush’s subcommittee.

FTC May Set Parameters Of Acceptable Brand/Generic Reverse Settlements

While the Federal Trade Commission is continuing its battle against reverse settlements, the agency concedes that not all deals are anticompetitive - and it would like to delineate which ones are acceptable

FTC May Set Parameters Of Acceptable Brand/Generic Reverse Settlements

While the Federal Trade Commission is continuing its battle against reverse settlements, the agency concedes that not all deals are anticompetitive - and it would like to delineate which ones are acceptable

Related Content

UsernamePublicRestriction

Register

PS048331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel